The US Food and Drug Administration received a 3% hike in funding for fiscal year 2022 under the omnibus budget agreement Congress recently passed and President Biden signed on 15 March.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?